Actio Biosciences, Inc.
Founded 2021 Β· 2 known investors
Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
BiotechDeep Tech
Founders & leadership
Actio Biosciences, Inc. was founded in 2021 by David Breckenridge.
DB
David BreckenridgeinFounder
Investors Β· 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJun 2025Source β
Source: company announcements and press reports β follow each round's link for the claim.
In the news
Frequently asked questions
- What does Actio Biosciences, Inc. do?
- Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
- Who founded Actio Biosciences, Inc.?
- Actio Biosciences, Inc. was founded by David Breckenridge in 2021.
- Who are Actio Biosciences, Inc.'s investors?
- Actio Biosciences, Inc.'s investors include Canaan Partners, EcoR1 Capital.